Adequate Pelvic Lymph Node Dissection in Radical Cystectomy in the Era of Neoadjuvant Chemotherapy: A Meta-Analysis and Systematic Review
Radical cystectomy (RC) with pelvic lymphadenectomy (PLND) serves as the gold-standard treatment for muscle-invasive bladder cancer (MIBC). Numerous studies have shown that the number of lymph nodes (LN) removed during RC could affect patient prognosis. However, these studies confirmed the associati...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/16/4040 |
_version_ | 1797585257791225856 |
---|---|
author | Krystian Kaczmarek Bartosz Małkiewicz Artur Lemiński |
author_facet | Krystian Kaczmarek Bartosz Małkiewicz Artur Lemiński |
author_sort | Krystian Kaczmarek |
collection | DOAJ |
description | Radical cystectomy (RC) with pelvic lymphadenectomy (PLND) serves as the gold-standard treatment for muscle-invasive bladder cancer (MIBC). Numerous studies have shown that the number of lymph nodes (LN) removed during RC could affect patient prognosis. However, these studies confirmed the association between PLND and survival outcomes prior to the widespread adoption of neoadjuvant chemotherapy (NAC). Consequently, this study aimed to investigate the prognostic role of PLND in patients previously pretreated with NAC. A systematic review and meta-analysis were performed using PubMed, Web of Knowledge, and Scopus databases. The selected studies contained a total of 17,421 participants. The meta-analysis indicated a significant correlation between adequate PLND and overall survival in the non-NAC group. However, a survival benefit was not observed in patients undergoing RC with preoperative systemic therapy, regardless of the LN cut-off thresholds. The pooled HR for ≥10 and ≥15 LN were 0.87 (95% CI 0.75–1.01) and 0.87 (95% CI 0.76–1.00), respectively. The study results suggest that NAC mitigates the therapeutic significance of PLND, as patients pre-treated with NAC no longer gain oncological benefits from more extensive lymphadenectomy. This highlights the analogous roles of NAC and PLND in eradication of micrometastases and in prevention of distal recurrence post-RC. |
first_indexed | 2024-03-11T00:04:31Z |
format | Article |
id | doaj.art-9406f48c617142288979811de12ca77b |
institution | Directory Open Access Journal |
issn | 2072-6694 |
language | English |
last_indexed | 2024-03-11T00:04:31Z |
publishDate | 2023-08-01 |
publisher | MDPI AG |
record_format | Article |
series | Cancers |
spelling | doaj.art-9406f48c617142288979811de12ca77b2023-11-19T00:32:17ZengMDPI AGCancers2072-66942023-08-011516404010.3390/cancers15164040Adequate Pelvic Lymph Node Dissection in Radical Cystectomy in the Era of Neoadjuvant Chemotherapy: A Meta-Analysis and Systematic ReviewKrystian Kaczmarek0Bartosz Małkiewicz1Artur Lemiński2Department of Urology and Urological Oncology, Pomeranian Medical University, Powstańców, Wielkopolskich 72, 70-111 Szczecin, PolandUniversity Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, 50-556 Wroclaw, PolandDepartment of Urology and Urological Oncology, Pomeranian Medical University, Powstańców, Wielkopolskich 72, 70-111 Szczecin, PolandRadical cystectomy (RC) with pelvic lymphadenectomy (PLND) serves as the gold-standard treatment for muscle-invasive bladder cancer (MIBC). Numerous studies have shown that the number of lymph nodes (LN) removed during RC could affect patient prognosis. However, these studies confirmed the association between PLND and survival outcomes prior to the widespread adoption of neoadjuvant chemotherapy (NAC). Consequently, this study aimed to investigate the prognostic role of PLND in patients previously pretreated with NAC. A systematic review and meta-analysis were performed using PubMed, Web of Knowledge, and Scopus databases. The selected studies contained a total of 17,421 participants. The meta-analysis indicated a significant correlation between adequate PLND and overall survival in the non-NAC group. However, a survival benefit was not observed in patients undergoing RC with preoperative systemic therapy, regardless of the LN cut-off thresholds. The pooled HR for ≥10 and ≥15 LN were 0.87 (95% CI 0.75–1.01) and 0.87 (95% CI 0.76–1.00), respectively. The study results suggest that NAC mitigates the therapeutic significance of PLND, as patients pre-treated with NAC no longer gain oncological benefits from more extensive lymphadenectomy. This highlights the analogous roles of NAC and PLND in eradication of micrometastases and in prevention of distal recurrence post-RC.https://www.mdpi.com/2072-6694/15/16/4040bladder cancerneoadjuvant chemotherapyradical cystectomylymphadenectomysurvival analysis |
spellingShingle | Krystian Kaczmarek Bartosz Małkiewicz Artur Lemiński Adequate Pelvic Lymph Node Dissection in Radical Cystectomy in the Era of Neoadjuvant Chemotherapy: A Meta-Analysis and Systematic Review Cancers bladder cancer neoadjuvant chemotherapy radical cystectomy lymphadenectomy survival analysis |
title | Adequate Pelvic Lymph Node Dissection in Radical Cystectomy in the Era of Neoadjuvant Chemotherapy: A Meta-Analysis and Systematic Review |
title_full | Adequate Pelvic Lymph Node Dissection in Radical Cystectomy in the Era of Neoadjuvant Chemotherapy: A Meta-Analysis and Systematic Review |
title_fullStr | Adequate Pelvic Lymph Node Dissection in Radical Cystectomy in the Era of Neoadjuvant Chemotherapy: A Meta-Analysis and Systematic Review |
title_full_unstemmed | Adequate Pelvic Lymph Node Dissection in Radical Cystectomy in the Era of Neoadjuvant Chemotherapy: A Meta-Analysis and Systematic Review |
title_short | Adequate Pelvic Lymph Node Dissection in Radical Cystectomy in the Era of Neoadjuvant Chemotherapy: A Meta-Analysis and Systematic Review |
title_sort | adequate pelvic lymph node dissection in radical cystectomy in the era of neoadjuvant chemotherapy a meta analysis and systematic review |
topic | bladder cancer neoadjuvant chemotherapy radical cystectomy lymphadenectomy survival analysis |
url | https://www.mdpi.com/2072-6694/15/16/4040 |
work_keys_str_mv | AT krystiankaczmarek adequatepelviclymphnodedissectioninradicalcystectomyintheeraofneoadjuvantchemotherapyametaanalysisandsystematicreview AT bartoszmałkiewicz adequatepelviclymphnodedissectioninradicalcystectomyintheeraofneoadjuvantchemotherapyametaanalysisandsystematicreview AT arturleminski adequatepelviclymphnodedissectioninradicalcystectomyintheeraofneoadjuvantchemotherapyametaanalysisandsystematicreview |